Plasma neuropeptide Y (NPY) was measured by radioimmunoassay in 43 patients with
congestive heart failure (CHF) and 20 healthy control subjects. The results showed that …

Abstract purpose: Our objectives were to assess whether plasma neuropeptide Y (NPY)
levels are elevated in patients with congestive heart failure (CHF) and whether or not NPY …

Neuropeptide Y (NPY) is thought to be co-released with catecholamines in response to
major cardiovascular stresses, but its relation to the release of catecholamines in response …

Abstract Aims Neuropeptide Y (NPY) is the most abundant neuropeptide found in the heart
and is released alongside norepinephrine following prolonged sympathetic activation, a …

Publisher Summary This chapter focuses on the attempts to further characterize the
relationship of NPY to NE release under physiological and pathophysiological conditions …

Neuropeptide-Y (NPY) is a sympathetic cotransmitter, which causes vasoconstriction,
decreases coronary blood flow and decreases cardiac output. Circulating immunoreactive …

Degree: D. Med. DegreeYear: 1994 Institute: Karolinska Institutet (Sweden) Publisher: Bengt
Ullman, Department Of Cardiology, South Hospital, S-118 83 Stockholm, Sweden. Plasma …

Plasma neuropeptide Y-like immunoreactivity (NPY-LI) is elevated in patients with acute
myocardial ischaemia and congestive heart failure (CHF) owing to increased activity of the …

OBJECTIVE To investigate the change characteristics of neuropeptide Y (NPY) release
during acute myocardial ischemia period. METHODS The animal test was carried out in in …

Neuropeptide Y (NPY) co-exists with norepinephrine (NE) in sympathetic terminals, and is
the most abundant neuropeptide in myocardium. Many studies have focused on the effects …